Female Urethra Adenocarcinoma.
Dell'Atti L, Galosi AB.
Clin Genitourin Cancer. 2018 Apr;16(2):e263-e267. doi: 10.1016/j.clgc.2017.10.006. Epub 2017 Oct 16.
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial.
Teoh JY, Cheng CH, Tsang CF, Kai-Man Li J, Kwun-Chung Cheng B, Hoi-Chak Chan W, Kwun-Wai Chan W, Churk-Fai Li T, Chiu Y, Law MC, Lok-Hei Leung C, Sze-Ho Ho B, Yue-Kit Lee C, Cheong-Kin Chan R, Shu-Yin Chan E, Chan MT, Hok-Leung Tsu J, Tam HM, Lam KM, So HS, Cho CL, Ng CM, Chan CK, Liu PL, Wing-Hong Chu R, Tsui-Lin Ng A, Chu SK, Yee CH, Yiu MK, Lo KL, Au WH, Ma WK, Ka-Fung Chiu P, Sze-Wan Kwok H, Yip SY, Leung CH, Ng CF; EB-StaR Study Group.
Eur Urol. 2024 Aug;86(2):103-111. doi: 10.1016/j.eururo.2024.04.015. Epub 2024 Apr 30.
Female urethral carcinoma.
Chu AM.
Radiology. 1973 Jun;107(3):627-30. doi: 10.1148/107.3.627.
Cystectomy in women.
Schilling D, Horstmann M, Nagele U, Sievert KD, Stenzl A.
BJU Int. 2008 Nov;102(9 Pt B):1289-95. doi: 10.1111/j.1464-410X.2008.07972.x.
[Penile cancer: diagnosis and staging].
Sievert KD, Dräger DL, Köhn FM, Milerski S, Protzel C, Hakenberg OW.
Urologe A. 2018 Apr;57(4):418-422. doi: 10.1007/s00120-018-0602-x.
Urologic Complications Following Pelvic Radiotherapy.
Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R.
Urology. 2018 Dec;122:1-9. doi: 10.1016/j.urology.2018.07.017. Epub 2018 Jul 20.
Follow-up Management of Cystectomy Patients.
Reddy M, Kader K.
Urol Clin North Am. 2018 May;45(2):241-247. doi: 10.1016/j.ucl.2018.01.001.
Mucinous and secondary tumors of the prostate.
Osunkoya AO.
Mod Pathol. 2018 Jan;31(S1):S80-S95. doi: 10.1038/modpathol.2017.132.
Urethral cancer.
Srinivas V, Khan SA.
Hosp Pract (Off Ed). 1985 May 15;20(5):147-8, 152-4. doi: 10.1080/21548331.1985.11703062.
Urethral tumor recurrences after radical cystoprostatectomy: the case for primary cystoprostatourethrectomy?
Stöckle M, Gökcebay E, Riedmiller H, Hohenfellner R.
J Urol. 1990 Jan;143(1):41-2; discussion 43. doi: 10.1016/s0022-5347(17)39858-0.
